Scientific Sessions 2024  /  Stroke Council Award and Keynote Lecture  /  Atrial Cardiopathy and Cryptogenic Stroke
Logo

American Heart Association

  109
  0

Final ID:

Atrial Cardiopathy and Cryptogenic Stroke

  • Kamel, Hooman  ( Weill Cornell Medicine , New York , New York , United States )
    • Author Disclosures:
    Hooman Kamel: DO have relevant financial relationships ; Other (please indicate in the box next to the company name):Financial disclosures for Hooman Kamel: a PI role in the ARCADIA trial, which received in-kind study drug from the BMS-Pfizer Alliance for Eliquis and ancillary study support from Roche Diagnostics; a Deputy Editor role for JAMA Neurology; clinical trial steering/executive committee roles for the STROKE-AF (Medtronic), LIBREXIA-AF (Janssen), and LAAOS-4 (Boston Scientific) trials; consulting or endpoint adjudication committee roles for AbbVie, AstraZeneca, Boehringer Ingelheim, and Novo Nordisk; and household ownership interests in TETMedical, Spectrum Plastics Group, and Ascential Technologies.:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Stroke Council Award and Keynote Lecture

Monday, 11/18/2024 , 08:00AM - 09:15AM

Abstract Oral Session

More abstracts on this topic:
Depression Symptomatology as Predictor of Incident Major Vascular Outcomes: Results from the Hispanic Community Health Study/Study of Latinos

Trifan Gabriela, Daviglus Martha, Pirzada Amber, Testai Fernando, Gallo Linda, Lamar Melissa, Wassertheil-smoller Sylvia, Gonzalez Hector, Perreira Krista, Cai Jianwen, Rundek Tatjana, Levin Bonnie

Cardiovascular outcomes with Glucagon-like Peptide-1 receptor agonists and Sodium-glucose Cotransporter-2 Inhibitors in patients with ischemic stroke in the community

Sheffeh Mohammad Ali, Estrada Magana Andres, Medina-inojosa Jose, Ortega Aviles Laura, Bianchettin Rosana, Medina-inojosa Betsy, Klaas James, Brown Robert, Lopez-jimenez Francisco

More abstracts from these authors:
The Trouble with ESUS: What do the studies tell us? Where do we do from here?

Kamel Hooman, Messe Steven

The Next Generation of Clinical Trials in Stroke Prevention: Crossing Borders

Kelly Peter, Kamel Hooman

You have to be authorized to contact abstract author. Please, Login
Not Available